Morphological Study of the Effects of the GnRH Superagonist Deslorelin on the Canine Testis and Prostate Gland
Junaidi, A., Williamson, P.E., Trigg, T.E., Cummins, J.M. and Martin, G.B. (2009) Morphological Study of the Effects of the GnRH Superagonist Deslorelin on the Canine Testis and Prostate Gland. Reproduction in Domestic Animals, 44 (5). pp. 757-763.
*Subscription may be required
Contents The present study is part of a programme of research designed to evaluate the efficacy of the GnRH superagonist, deslorelin (d-Trp 6-Pro 9-des-Gly 10-LHRH ethylamide), as a contraceptive for male dogs. Adult dogs were assigned to a completely randomized design comprising six groups of four animals. Each dog in the control group received a blank implant (placebo) and each dog in the other five groups received a 6 mg deslorelin implant. One group of deslorelin-treated dogs was sacrificed on each of days 16, 26, 41, 101 and 620, and testicular and prostate tissues were collected for study by light and electron microscopy. On days 16 and 26 after implantation, we observed partial disruption of the seminiferous tubules, with early spermatids shed into the lumen. On days 41 and 101 after implantation, 90-100% of the seminiferous tubules were atrophic and aspermatogenic. On day 101 after implantation, 99% of all sections showed atrophy of the epithelium and shrinkage of epithelial height in the ductus epididymides. On days 41 and 101 after implantation, prostate tissue showed complete atrophy of the glandular epithelium (100% of sections) and an apparent increase in the relative proportion of connective tissue. At the electron microscopic level, in dogs treated with deslorelin for 41 and 101 days, the Sertoli cells were smaller and their nucleoli appeared smaller than in the control dogs. The nucleoli of the Leydig cells were atrophied and prostate glandular epithelium showed reduced epithelial height, atrophy of the nucleolus and an absence of secretory granules. Tissues collected during the recovery phase revealed a complete recovery of spermatogenesis. In conclusion, slow-release implants containing deslorelin induce a striking atrophy of the testes and prostate gland by 26 days after implantation, explaining the previously reported loss of ejaculate and arrest of sperm output. At histological level, the entire process appears to be completely reversible, in accordance with data on endocrine variables and semen production.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||School of Veterinary and Biomedical Sciences|
|Publisher:||Blackwell Publishing Inc.|
|Copyright:||© 2008 Blackwell Verlag|
|Item Control Page|